FDA has issued guidance for industry to help infant formula manufacturers and distributors comply with certain labeling requirements for infant formula products.
While the major provisions of the FSMA rules are being implemented as planned, the FDA has issued a final rule that extends and clarifies the compliance dates for certain provisions in four of the seven foundational rules.
The agency released a final rule for the criteria needed to conclude an ingredient is “generally recognized as safe” (GRAS) for use in human or animal food.
In 2014, FDA adopted a new, proactive sampling program for a variety of commodities to learn more about the prevalence of disease-causing bacteria and to help the agency identify patterns that may help predict and prevent future contamination.